Crawford Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $193M | Sell |
886,415
-7,161
| -0.8% | -$1.59M | 3.29% | 1 |
|
|
2025
Q4 | $204M | Sell |
893,576
-17,123
| -2% | -$3.9M | 3.4% | 2 |
|
|
2025
Q3 | $211M | Buy |
910,699
+7,906
| +0.9% | +$1.61M | 3.49% | 2 |
|
|
2025
Q2 | $168M | Sell |
902,793
-25,250
| -3% | -$4.69M | 2.93% | 2 |
|
|
2025
Q1 | $194M | Sell |
928,043
-31,767
| -3% | -$6.18M | 3.45% | 1 |
|
|
2024
Q4 | $171M | Buy |
959,810
+9,032
| +0.9% | +$1.66M | 3.07% | 2 |
|
|
2024
Q3 | $188M | Sell |
950,778
-14,062
| -1% | -$2.62M | 3.21% | 2 |
|
|
2024
Q2 | $165M | Buy |
964,840
+8,808
| +0.9% | +$1.46M | 3.15% | 2 |
|
|
2024
Q1 | $174M | Sell |
956,032
-30,915
| -3% | -$5.33M | 3.24% | 2 |
|
|
2023
Q4 | $153M | Sell |
986,947
-14,318
| -1% | -$2.09M | 3.07% | 2 |
|
|
2023
Q3 | $149M | Buy |
1,001,265
+7,693
| +0.8% | +$1.13M | 3.24% | 2 |
|
|
2023
Q2 | $134M | Buy |
993,572
+10,905
| +1% | +$1.6M | 2.72% | 2 |
|
|
2023
Q1 | $157M | Sell |
982,667
-32,030
| -3% | -$4.9M | 3.34% | 2 |
|
|
2022
Q4 | $164M | Sell |
1,014,697
-21,227
| -2% | -$3.25M | 3.53% | 1 |
|
|
2022
Q3 | $139M | Sell |
1,035,924
-4,775
| -0.5% | -$685K | 3.29% | 1 |
|
|
2022
Q2 | $159M | Sell |
1,040,699
-131,360
| -11% | -$20.1M | 3.52% | 1 |
|
|
2022
Q1 | $190M | Sell |
1,172,059
-51,404
| -4% | -$7.47M | 3.68% | 1 |
|
|
2021
Q4 | $166M | Sell |
1,223,463
-2,783
| -0.2% | -$329K | 3.15% | 2 |
|
|
2021
Q3 | $132M | Buy |
1,226,246
+17,797
| +1% | +$2.03M | 2.7% | 3 |
|
|
2021
Q2 | $136M | Buy |
1,208,449
+87,391
| +8% | +$9.84M | 2.75% | 3 |
|
|
2021
Q1 | $121M | Buy |
1,121,058
+59,078
| +6% | +$6.32M | 2.74% | 3 |
|
|
2020
Q4 | $114M | Buy |
1,061,980
+20,863
| +2% | +$2M | 2.81% | 2 |
|
|
2020
Q3 | $91.2M | Sell |
1,041,117
-8,927
| -0.9% | -$840K | 2.49% | 7 |
|
|
2020
Q2 | $103M | Sell |
1,050,044
-32,013
| -3% | -$2.82M | 2.96% | 3 |
|
|
2020
Q1 | $82.4M | Buy |
1,082,057
+75,830
| +8% | +$6.46M | 2.77% | 4 |
|
|
2019
Q4 | $89.1M | Buy |
1,006,227
+51,209
| +5% | +$4.25M | 2.3% | 7 |
|
|
2019
Q3 | $72.3M | Buy |
955,018
+926,607
| +3,261% | +$63.5M | 2.01% | 14 |
|
|
2019
Q2 | $2.07M | Buy |
28,411
+155
| +0.5% | +$12.2K | 0.06% | 150 |
|
|
2019
Q1 | $2.28M | Buy |
28,256
+563
| +2% | +$46.1K | 0.07% | 149 |
|
|
2018
Q4 | $2.55M | Buy |
27,693
+3,100
| +13% | +$273K | 0.09% | 123 |
|
|
2018
Q3 | $2.33M | Sell |
24,593
-150
| -0.6% | -$14.2K | 0.07% | 139 |
|
|
2018
Q2 | $2.29M | Buy |
24,743
+894
| +4% | +$87.3K | 0.07% | 134 |
|
|
2018
Q1 | $2.26M | Buy |
23,849
+192
| +0.8% | +$21.1K | 0.07% | 129 |
|
|
2017
Q4 | $2.29M | Buy |
23,657
+1,178
| +5% | +$111K | 0.07% | 128 |
|
|
2017
Q3 | $2M | Buy |
22,479
+585
| +3% | +$44.5K | 0.06% | 129 |
|
|
2017
Q2 | $1.59M | Sell |
21,894
-460
| -2% | -$30.9K | 0.05% | 136 |
|
|
2017
Q1 | $1.46M | Buy |
22,354
+1,039
| +5% | +$65.3K | 0.05% | 141 |
|
|
2016
Q4 | $1.33M | Buy |
21,315
+81
| +0.4% | +$4.94K | 0.05% | 150 |
|
|
2016
Q3 | $1.34M | Sell |
21,234
-3,147
| -13% | -$204K | 0.05% | 150 |
|
|
2016
Q2 | $1.51M | Sell |
24,381
-70
| -0.3% | -$4.26K | 0.06% | 131 |
|
|
2016
Q1 | $1.4M | Sell |
24,451
-3,646
| -13% | -$203K | 0.06% | 129 |
|
|
2015
Q4 | $1.66M | Sell |
28,097
-676
| -2% | -$38.9K | 0.07% | 111 |
|
|
2015
Q3 | $1.57M | Buy |
28,773
+2,739
| +11% | +$178K | 0.07% | 118 |
|
|
2015
Q2 | $1.75M | Sell |
26,034
-3,131
| -11% | -$204K | 0.07% | 115 |
|
|
2015
Q1 | $1.71M | Sell |
29,165
-653
| -2% | -$39.4K | 0.06% | 117 |
|
|
2014
Q4 | $1.95M | Hold |
29,818
| – | – | 0.07% | 100 |
|
|
2014
Q3 | $1.72M | Sell |
29,818
-3,432
| -10% | -$191K | 0.06% | 96 |
|
|
2014
Q2 | $1.88M | Hold |
33,250
| – | – | 0.07% | 87 |
|
|
2014
Q1 | $1.71M | Sell |
33,250
-7,650
| -19% | -$387K | 0.06% | 88 |
|
|
2013
Q4 | $2.16M | Buy |
40,900
+2,725
| +7% | +$134K | 0.08% | 81 |
|
|
2013
Q3 | $1.71M | Buy |
38,175
+214
| +0.6% | +$9.49K | 0.07% | 86 |
|
|
2013
Q2 | $1.57M | Buy |
+37,961
| New | +$1.66M | 0.06% | 87 |
|
Other funds holding ABBV
VCM
VPM
Crawford Investment Counsel's ABBV Position: Q1 2026 in Review
Crawford Investment Counsel reduced its AbbVie (ABBV) stake by 0.8% in Q1 2026, selling an estimated $1.59M and leaving 886,415 shares worth $193M. The position accounts for 3.29% of the portfolio, ranked #1.
Crawford Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $211M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Crawford Investment Counsel held 886,415 shares of AbbVie worth $193M as of Q1 2026.
- Crawford Investment Counsel sold 7,161 AbbVie shares in Q1 2026, an estimated $1.59M.
- AbbVie made up 3.29% of Crawford Investment Counsel's portfolio in Q1 2026, its #1 holding.
- Crawford Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Crawford Investment Counsel's AbbVie position peaked at $211M in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.